Hyperfine (HYPR) Notes Payables (2020)
Hyperfine's (HYPR) quarterly Notes Payables came in at $38375.0 in Q4 2020.
Hyperfine (HYPR) Notes Payables (2020) Analysis & Trends
Hyperfine (HYPR) has 1 years of Notes Payables data on file, last reported at $38375.0 in Q4 2020.
- Quarterly Notes Payables changed N/A year-over-year to $38375.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $38375.0 (changed N/A YoY) and the FY2020 annual result came in at $38375.0, changed N/A from the prior year.
- Notes Payables steadied at $38375.0 in Q4 2020.
- In the past five years, Notes Payables ranged from a high of $38375.0 in Q4 2020 to a low of $38375.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Hyperfine | 90.12 Mn | 45.35 Mn | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 38,375.00 |